Last reviewed · How we verify
Live Combined Bifidobacterium and Lactobacillus — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Live Combined Bifidobacterium and Lactobacillus (Live Combined Bifidobacterium and Lactobacillus) — First Affiliated Hospital Xi'an Jiaotong University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Live Combined Bifidobacterium and Lactobacillus TARGET | Live Combined Bifidobacterium and Lactobacillus | First Affiliated Hospital Xi'an Jiaotong University | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Live Combined Bifidobacterium and Lactobacillus CI watch — RSS
- Live Combined Bifidobacterium and Lactobacillus CI watch — Atom
- Live Combined Bifidobacterium and Lactobacillus CI watch — JSON
- Live Combined Bifidobacterium and Lactobacillus alone — RSS
Cite this brief
Drug Landscape (2026). Live Combined Bifidobacterium and Lactobacillus — Competitive Intelligence Brief. https://druglandscape.com/ci/live-combined-bifidobacterium-and-lactobacillus. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab